MedPath

The Chinese University of Hong Kong

The Chinese University of Hong Kong logo
🇨🇳China
Ownership
Private
Established
1963-01-01
Employees
-
Market Cap
-
Website
http://www.cuhk.edu.hk

Community Health Worker Reduces Care Utilization

Phase 4
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Other: Protocol-driven care under JADE Program
Other: Additional support by CHW
First Posted Date
2008-07-08
Last Posted Date
2015-09-09
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
661
Registration Number
NCT00711152
Locations
🇭🇰

Asia Diabetes Foundation, Hong Kong, Hong Kong

The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome

Phase 2
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Drug: Traditional Chinese Medicine Placebo
Drug: Traditional Chinese Medicine
First Posted Date
2008-05-13
Last Posted Date
2017-04-25
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
104
Registration Number
NCT00676975
Locations
🇨🇳

Li Ka Shing Specialist Clinic, Prince of Wales Hospital, Hong Kong (SAR), China

Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus

Phase 4
Completed
Conditions
Systemic Lupus Erythematosus
Interventions
Drug: Ibandronate+alfacalcidol+calcium
Drug: placebo ibandronate+alfacalcidol+calcium
First Posted Date
2008-04-29
Last Posted Date
2012-02-13
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
40
Registration Number
NCT00668330
Locations
🇨🇳

School of Pharmacy CUHK, Hong Kong, China

Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma

Phase 1
Completed
Conditions
Asthma
Interventions
Other: Placebo
First Posted Date
2008-03-14
Last Posted Date
2008-03-14
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
90
Registration Number
NCT00636103
Locations
🇭🇰

Department of Paediatrics, Prince of Wales Hospital, Hong Kong, Hong Kong

🇭🇰

Department of Paediatrics, Tuen Mun Hospital, Hong Kong, Hong Kong

Validation of Portable Monitoring Device for Diagnosing Sleep Apnea

Completed
Conditions
Sleep Apnea
Interventions
Device: ARES (Apnea Risk Evaluation System)
First Posted Date
2008-03-05
Last Posted Date
2016-02-09
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
175
Registration Number
NCT00628511
Locations
🇨🇳

The Chinese Univerisity of Hong Kong, Hong Kong, China

Paricalcitol for the Treatment of Immunoglobulin A Nephropathy

Phase 3
Withdrawn
Conditions
IgA Nephropathy
Interventions
First Posted Date
2008-01-24
Last Posted Date
2015-08-03
Lead Sponsor
Chinese University of Hong Kong
Registration Number
NCT00599963
Locations
🇭🇰

Department of Medicine & Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong

Lingzhi for Cancer Children

Phase 3
Completed
Conditions
Pediatric Cancers
Interventions
Drug: LingZhi capsule
First Posted Date
2007-12-18
Last Posted Date
2007-12-18
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
58
Registration Number
NCT00575926
Locations
🇭🇰

Department of Pediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong, Hong Kong

🇭🇰

Department of Pediatrics, Queen Elizabeth Hospital, Hong Kong, Hong Kong

🇭🇰

Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong

Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus

Phase 2
Completed
Conditions
Systemic Lupus Erythematosus
Interventions
First Posted Date
2007-11-09
Last Posted Date
2012-02-13
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
20
Registration Number
NCT00556192
Locations
🇨🇳

Department of Medicine and Therapeutics, Hong Kong, China

Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Interventions
Drug: Placebo
First Posted Date
2007-11-08
Last Posted Date
2011-01-27
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
150
Registration Number
NCT00555230
Locations
🇨🇳

School of Pharmacy CUHK, Hong Kong, China

An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2007-11-08
Last Posted Date
2008-05-09
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
10
Registration Number
NCT00555542
Locations
🇨🇳

Department of Medicine and Therapeutics, Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath